12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Company News  |  Deals

Molecular Partners, Roche deal

Molecular Partners and Roche partnered to generate conjugates of toxic agents from Roche with Molecular Partners' designed ankyrin repeat proteins (DARPins) against a set of undisclosed targets for cancer. Molecular Partners will receive undisclosed research funding and up...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >